clinical trials, page-38

If it is Mars Construction who sold (and I think it was as I am suspicious that MF has links with iSonea and therefore quick access to this sort of info), it's a bit of a worry as to why they've now decided to sell at such low levels. They had 9.6mill shares in June 2010,10mill in Jan 2011, 17.5mill in Dec 2011, and now have decided to dump it all. What has changed for them to turn from an accumulator to cutting their investment all together?

I suspect a big diluting placement is on the way.